Literature DB >> 20564069

Mediating effects of smoking and chronic obstructive pulmonary disease on the relation between the CHRNA5-A3 genetic locus and lung cancer risk.

Jian Wang1, Margaret R Spitz, Christopher I Amos, Anna V Wilkinson, Xifeng Wu, Sanjay Shete.   

Abstract

BACKGROUND: Recent genome-wide association studies of lung cancer have shown that the CHRNA5-A3 region on chromosome 15q24-25.1 is strongly associated with an increased risk of lung cancer and nicotine dependence, and is thought to be associated with chronic obstructive pulmonary disease as well. However, it has not been established whether the association between genetic variants and lung cancer risk is a direct one or one mediated by nicotine dependence.
METHODS: The authors applied a rigorous statistical approach, mediation analysis, to examine the mediating effect of smoking behavior and self-reported, physician-diagnosed emphysema (chronic obstructive pulmonary disease [COPD]) on the relation between the CHRNA5-A3 region genetic variant rs1051730 and the risk of lung cancer.
RESULTS: Our results showed that rs1051730 is directly associated with lung cancer risk, but it is also associated with lung cancer risk through its effect on both smoking behavior and COPD. Furthermore, we showed that COPD is a mediating phenotype that explains part of the effect of smoking behavior on lung cancer. Our results also suggested that smoking behavior is a mediator of the relation between rs1051730 and COPD risk.
CONCLUSIONS: Smoking behavior and COPD are mediators of the association between the single nucleotide polymorphism (SNP) rs1051730 and the risk of lung cancer. Also, COPD is a mediator of the association between smoking behavior and lung cancer. Finally, smoking behavior also has mediating effects on the association between the SNP and COPD. Copyright (c) 2010 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20564069      PMCID: PMC3073819          DOI: 10.1002/cncr.25085

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  15 in total

1.  Mediation in experimental and nonexperimental studies: new procedures and recommendations.

Authors:  Patrick E Shrout; Niall Bolger
Journal:  Psychol Methods       Date:  2002-12

2.  Development and validation of a survey-based COPD severity score.

Authors:  Mark D Eisner; Laura Trupin; Patricia P Katz; Edward H Yelin; Gillian Earnest; John Balmes; Paul D Blanc
Journal:  Chest       Date:  2005-06       Impact factor: 9.410

3.  SPSS and SAS procedures for estimating indirect effects in simple mediation models.

Authors:  Kristopher J Preacher; Andrew F Hayes
Journal:  Behav Res Methods Instrum Comput       Date:  2004-11

4.  The intermediate endpoint effect in logistic and probit regression.

Authors:  D P MacKinnon; C M Lockwood; C H Brown; W Wang; J M Hoffman
Journal:  Clin Trials       Date:  2007       Impact factor: 2.486

5.  A risk model for prediction of lung cancer.

Authors:  Margaret R Spitz; Waun Ki Hong; Christopher I Amos; Xifeng Wu; Matthew B Schabath; Qiong Dong; Sanjay Shete; Carol J Etzel
Journal:  J Natl Cancer Inst       Date:  2007-05-02       Impact factor: 13.506

6.  The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations.

Authors:  R M Baron; D A Kenny
Journal:  J Pers Soc Psychol       Date:  1986-12

7.  Validation of self-reported chronic obstructive pulmonary disease in a cohort study of nurses.

Authors:  R Graham Barr; Julie Herbstman; Frank E Speizer; Carlos A Camargo
Journal:  Am J Epidemiol       Date:  2002-05-15       Impact factor: 4.897

8.  A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25.

Authors:  Rayjean J Hung; James D McKay; Valerie Gaborieau; Paolo Boffetta; Mia Hashibe; David Zaridze; Anush Mukeria; Neonilia Szeszenia-Dabrowska; Jolanta Lissowska; Peter Rudnai; Eleonora Fabianova; Dana Mates; Vladimir Bencko; Lenka Foretova; Vladimir Janout; Chu Chen; Gary Goodman; John K Field; Triantafillos Liloglou; George Xinarianos; Adrian Cassidy; John McLaughlin; Geoffrey Liu; Steven Narod; Hans E Krokan; Frank Skorpen; Maiken Bratt Elvestad; Kristian Hveem; Lars Vatten; Jakob Linseisen; Françoise Clavel-Chapelon; Paolo Vineis; H Bas Bueno-de-Mesquita; Eiliv Lund; Carmen Martinez; Sheila Bingham; Torgny Rasmuson; Pierre Hainaut; Elio Riboli; Wolfgang Ahrens; Simone Benhamou; Pagona Lagiou; Dimitrios Trichopoulos; Ivana Holcátová; Franco Merletti; Kristina Kjaerheim; Antonio Agudo; Gary Macfarlane; Renato Talamini; Lorenzo Simonato; Ray Lowry; David I Conway; Ariana Znaor; Claire Healy; Diana Zelenika; Anne Boland; Marc Delepine; Mario Foglio; Doris Lechner; Fumihiko Matsuda; Helene Blanche; Ivo Gut; Simon Heath; Mark Lathrop; Paul Brennan
Journal:  Nature       Date:  2008-04-03       Impact factor: 49.962

9.  A variant associated with nicotine dependence, lung cancer and peripheral arterial disease.

Authors:  Thorgeir E Thorgeirsson; Frank Geller; Patrick Sulem; Thorunn Rafnar; Anna Wiste; Kristinn P Magnusson; Andrei Manolescu; Gudmar Thorleifsson; Hreinn Stefansson; Andres Ingason; Simon N Stacey; Jon T Bergthorsson; Steinunn Thorlacius; Julius Gudmundsson; Thorlakur Jonsson; Margret Jakobsdottir; Jona Saemundsdottir; Olof Olafsdottir; Larus J Gudmundsson; Gyda Bjornsdottir; Kristleifur Kristjansson; Halla Skuladottir; Helgi J Isaksson; Tomas Gudbjartsson; Gregory T Jones; Thomas Mueller; Anders Gottsäter; Andrea Flex; Katja K H Aben; Femmie de Vegt; Peter F A Mulders; Dolores Isla; Maria J Vidal; Laura Asin; Berta Saez; Laura Murillo; Thorsteinn Blondal; Halldor Kolbeinsson; Jon G Stefansson; Ingunn Hansdottir; Valgerdur Runarsdottir; Roberto Pola; Bengt Lindblad; Andre M van Rij; Benjamin Dieplinger; Meinhard Haltmayer; Jose I Mayordomo; Lambertus A Kiemeney; Stefan E Matthiasson; Hogni Oskarsson; Thorarinn Tyrfingsson; Daniel F Gudbjartsson; Jeffrey R Gulcher; Steinn Jonsson; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  Nature       Date:  2008-04-03       Impact factor: 49.962

10.  Smokers with the CHRNA lung cancer-associated variants are exposed to higher levels of nicotine equivalents and a carcinogenic tobacco-specific nitrosamine.

Authors:  Loïc Le Marchand; Kiersten S Derby; Sharon E Murphy; Stephen S Hecht; Dorothy Hatsukami; Steven G Carmella; Maarit Tiirikainen; Hansong Wang
Journal:  Cancer Res       Date:  2008-11-15       Impact factor: 12.701

View more
  39 in total

1.  Genetic variants on 15q25.1, smoking, and lung cancer: an assessment of mediation and interaction.

Authors:  Tyler J VanderWeele; Kofi Asomaning; Eric J Tchetgen Tchetgen; Younghun Han; Margaret R Spitz; Sanjay Shete; Xifeng Wu; Valerie Gaborieau; Ying Wang; John McLaughlin; Rayjean J Hung; Paul Brennan; Christopher I Amos; David C Christiani; Xihong Lin
Journal:  Am J Epidemiol       Date:  2012-02-03       Impact factor: 4.897

2.  Recent advances in the genetic epidemiology and molecular genetics of substance use disorders.

Authors:  Kenneth S Kendler; Xiangning Chen; Danielle Dick; Hermine Maes; Nathan Gillespie; Michael C Neale; Brien Riley
Journal:  Nat Neurosci       Date:  2012-01-26       Impact factor: 24.884

3.  Association between CHRNA3 rs1051730 genotype and lung cancer risk in Chinese Han population: a case-control study.

Authors:  Jing-Hua Ren; Min Jin; Wen-Shan He; Cui-Wei Liu; Shun Jiang; Wei-Hong Chen; Kun-Yu Yang; Gang Wu; Tao Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-12-13

4.  CGene: an R package for implementation of causal genetic analyses.

Authors:  Peter J Lipman; Christoph Lange
Journal:  Eur J Hum Genet       Date:  2011-07-06       Impact factor: 4.246

5.  Disease risk factors identified through shared genetic architecture and electronic medical records.

Authors:  Li Li; David J Ruau; Chirag J Patel; Susan C Weber; Rong Chen; Nicholas P Tatonetti; Joel T Dudley; Atul J Butte
Journal:  Sci Transl Med       Date:  2014-04-30       Impact factor: 17.956

6.  Duplicated copy of CHRNA7 increases risk and worsens prognosis of COPD and lung cancer.

Authors:  Lei Yang; Xiaoxiao Lu; Fuman Qiu; Wenxiang Fang; Lisha Zhang; Dongsheng Huang; Chenli Xie; Nanshan Zhong; Pixin Ran; Yifeng Zhou; Jiachun Lu
Journal:  Eur J Hum Genet       Date:  2014-11-19       Impact factor: 4.246

7.  Mediation analysis in a case-control study when the mediator is a censored variable.

Authors:  Jian Wang; Jing Ning; Sanjay Shete
Journal:  Stat Med       Date:  2018-11-12       Impact factor: 2.373

8.  A Fast and Accurate Method for Genome-wide Scale Phenome-wide G × E Analysis and Its Application to UK Biobank.

Authors:  Wenjian Bi; Zhangchen Zhao; Rounak Dey; Lars G Fritsche; Bhramar Mukherjee; Seunggeun Lee
Journal:  Am J Hum Genet       Date:  2019-11-14       Impact factor: 11.025

9.  Estimation of indirect effect when the mediator is a censored variable.

Authors:  Jian Wang; Sanjay Shete
Journal:  Stat Methods Med Res       Date:  2017-01-30       Impact factor: 3.021

10.  ATF3 and extracellular matrix-related genes associated with the process of chronic obstructive pulmonary.

Authors:  Jia Ye; Li Wen; De-Ling Liu; Guo-xiang Lai
Journal:  Lung       Date:  2014-08-14       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.